Please assess the completion status of the following clinical trial:

Trial Title: Steroid-Antiviral Treatment in Rehabilitation of Facial Palsy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Acute onset facial palsy within the first three days of onset. Age ranged from 15-60 years old~Exclusion Criteria:~* Patients with brittle diabetes mellitus, Morbid obesity, renal or liver impairment, osteopenia, prior history of steroid intolerance.

- Gender: ALL
- Minimum Age: 15 Years
- Maximum Age: 60 Years
- Healthy Volunteers: f

Study Arms:
- Steroid Group (Type: ACTIVE_COMPARATOR): prednisolone 60 mg /day IM /IV for 6 consecutive days then reduced by 10 mg /day (for a total treatment time for 12 days)
- Steroid + Antiviral Group (Type: ACTIVE_COMPARATOR): Prednisolone IM/ IV 60 mg /day + IV acyclovir 500 mg three time /day for 6 consecutive days) then reduced by 10 mg /day (for a total treatment time for 12 days)

Based on this trial design, predict the completion outcome and termination type (if applicable).